Filters
International cell therapy and immunotherapy consortium (EE2.3.20.0012)
The project is to establish the International Consortium for cell therapy and immunotherapy dealing with the therapeutic use of stem cells, dendritic cells and lymphocytes in human medicine. In this project we expect to deepen existing or es...
EC - Imunologie
- 2011 - 2014 •
- 15 329 tis. Kč •
- 15 329 tis. Kč •
- MŠMT
Řešení projektu: 1. 7. 2011 - 30. 6. 2014
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo školství, mládeže a tělovýchovy
Bee venom allergy (anaphylaxis) - basophil stimulation test and immunoblotting of allergic patients after immunotherapy (NI6349)
The distinguishion between rectors and nonreactors of Hymenoptera venom allergic patients during or after immunotherapy will be made on the basis of basophil stimulation test and immunoblot study.......
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2000 - 2002 •
- 1 162 tis. Kč •
- 1 161 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2000 - 1. 1. 2002
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Comparison of efficacy of two allergen immunotherapy application forms (sublingual and subcutaneous) in treatment of pollinosis, using clinical and laboratory parameters (NI7470)
Clinical study aimed to mutual comparison of therapeutical efficacy of two allergen immunotherapy application forms (sublingual and subcutaneous), using clinical and laboratory parameters. Observation of time factors of changes onset in clin...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2003 - 2005 •
- 2 205 tis. Kč •
- 2 179 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2003 - 1. 1. 2005
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Ministerstvo zdravotnictví
Immunotherapy of chronic myeloid leukemia therapeutic vaccines in a mouse model and preparation of a clinical study (NC6957)
Creation of prerequisites for immunotherapy of chronic myeloid leukemia: development and testing of experimental vaccines against tumours expressing BCR_ABL fusion protein Immunological characterization of chronic myeloid leukemia patients: ...
FD - Onkologie a hematologie
- 2002 - 2004 •
- 14 158 tis. Kč •
- 13 385 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2002 - 1. 1. 2004
Uznané náklady
Podpora ze státního rozpočtu (95%)
Poskytovatel: Ministerstvo zdravotnictví
Evaluation of Cellular Immunity and Molecular Analysis of Myeloma-Specific T cells in Patients with Multiple Myeloma (NC7475)
The aim of this study is to identify and characterize myeloma-specific T cells in patients with multiple myeloma. Immunocompetent cells will be evaluated before, during and after immunotherapy in patients with multiple myeloma Differencies o...
FD - Onkologie a hematologie
- 2003 - 2005 •
- 2 498 tis. Kč •
- 2 404 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2003 - 1. 1. 2005
Uznané náklady
Podpora ze státního rozpočtu (96%)
Poskytovatel: Ministerstvo zdravotnictví
Mechanisms of immunoresistance in glioblastoma (NS9875)
Submitted project deals with the immunosuppresive effects of glioblastoma cells caused by overexpression of transforming growth factor beta and contributes to enhancement of current cellular immunotherapy.......
FD - Onkologie a hematologie
- 2008 - 2011 •
- 9 724 tis. Kč •
- 9 724 tis. Kč •
- MZ
Řešení projektu: 1. 7. 2008 - 31. 12. 2011
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Generation of dendritic cells in vitro, their characteristics, antigen presenting capacity and potential use in the immunotherapy of minimal residual disease in (NI5669)
immunotherapy of minimal residual disease of childhood leukemia, but methodological aspects investigated in this proposal can be used in the future immunotherapy in different kinds......
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 1999 - 2001 •
- 1 362 tis. Kč •
- 1 362 tis. Kč •
- MZ
Řešení projektu: 1. 1. 1999 - 1. 1. 2001
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Combinatorial treatment strategies to overcome immunotherapy resistance in soft tissue sarcomas (NU23J-08-00031)
and their prognostic potential [1-4]. The immunotherapy with immune checkpoint inhibitors (ICIs) with long-term treatment responses [5-8]. The response to immunotherapy, however, varies of primary and acquired immunotherapy
Immunology
- 2023 - 2026 •
- 5 960 tis. Kč •
- 5 960 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2023 - 31. 12. 2026
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
MBTA - adoptive immunotherapy of tumors (FW12010389)
The goal of the project is, through industrial research and experimental development, to develop a proven technology for the production of medicinal substances in the correct laboratory quality (SLK) for the treatment of malignant tumors, which will ...
Oncology
- 2025 - 2027 •
- 24 756 tis. Kč •
- 17 305 tis. Kč •
- TA ČR
Řešení projektu: 1. 1. 2025 - 31. 12. 2027
Uznané náklady
Podpora ze státního rozpočtu (70%)
Poskytovatel: Technologická agentura ČR
Adfoptive immunotherapy as a part of the combined treatment of liver metastases (NI4676)
Present project is a study of the feasibility of local immunotherapy of mestatic involvement of the liver. Preclinical part will deal with the methodology of obtaining and culture of antitumor effectors and study of their interaction with ch...
FD - Onkologie a hematologie
- 1998 - 2000 •
- 7 229 tis. Kč •
- 3 916 tis. Kč •
- MZ
Řešení projektu: 1. 1. 1998 - 1. 1. 2000
Uznané náklady
Podpora ze státního rozpočtu (54%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 10 out of 141